{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:50:37Z","timestamp":1791287437502,"version":"4.1.0"},"reference-count":80,"publisher":"Croatian Society for Medical Biochemistry and Laboratory Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochem. med. (Online)"],"published-print":{"date-parts":[[2026,10,15]]},"abstract":"<jats:p>The International Normalized Ratio (INR), introduced by the World Health Organization in 1983, is central to vitamin K antagonist (VKA) therapy monitoring. However, thromboplastin standardization alone does not ensure harmonized prothrombin time (PT)\/INR results. Residual variability arises throughout the testing continuum. In this narrative review, we examine the principal sources of residual PT\/INR non-equivalence across the \u201cvein-to-report\u201d pathway. Particular attention is devoted to clinical settings in which the assumptions underlying INR calibration are only partially satisfied, including advanced liver disease and exposure to direct oral anticoagulants. We further discuss postanalytical factors, such as determination of the mean normal prothrombin time and system-specific verification of the International Sensitivity Index, as well as quality assurance strategies, including the use of commutable external quality assessment materials and patient-based real-time quality control. Prothrombin time\/INR harmonization requires integrating preanalytical practices, recognizing reagent-instrument dependencies, and quality strategies reflecting real-world testing conditions.<\/jats:p>","DOI":"10.11613\/bm.2026.030504","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:07:24Z","timestamp":1790932044000},"page":"474-487","source":"Crossref","is-referenced-by-count":0,"title":["Challenges in PT\/INR harmonization across the total testing process"],"prefix":"10.11613","volume":"36","author":[{"given":"Jia-min","family":"Zou","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Luzhou Mental Hospital, Luzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-ji","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Luzhou Mental Hospital, Luzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, People\u2019s Hospital of Naxi District, Luzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-gang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, People\u2019s Hospital of Naxi District, Luzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4885","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"key20261002090717_r1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/ijlh.13585","article-title":"Review of coagulation preanalytical variables with update on the effect of direct oral anticoagulants.","volume":"43","author":"Gosselin","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"key20261002090717_r2","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/ijlh.13702","article-title":"International Council for Standardization in Haematology (ICSH) recommendations for processing of blood samples for coagulation testing.","volume":"43","author":"Kitchen","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"key20261002090717_r3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1538-7836.2004.00775.x","article-title":"International Normalized Ratios (INR): the first 20 years.","volume":"2","author":"Poller","year":"2004","journal-title":"J Thromb Haemost"},{"key":"key20261002090717_r4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ijlh.13349","article-title":"Standardization of Prothrombin Time\/International Normalized Ratio (PT\/INR).","volume":"43","author":"Dorgalaleh","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"key20261002090717_r5","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jtha.2023.12.013","article-title":"Defining a metrologically traceable and sustainable calibration hierarchy of international normalized ratio for monitoring of vitamin K antagonist treatment in accordance with International Organization for Standardization (ISO) 17511:2020 standard: communication from the International Federation of Clinical Chemistry and Laboratory Medicine-SSC\/ISTH working group on prothrombin time\/international normalized ratio standardization.","volume":"22","author":"van den Besselaar","year":"2024","journal-title":"J Thromb Haemost"},{"key":"key20261002090717_r6","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1111\/jth.14873","article-title":"Paving the way for establishing a reference measurement system for standardization of plasma prothrombin time: Harmonizing the manual tilt tube method.","volume":"18","author":"van den Besselaar","year":"2020","journal-title":"J Thromb Haemost"},{"key":"key20261002090717_r7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0038-1657371","article-title":"Calibration of reference thromboplastins and standardisation of the prothrombin time ratio.","volume":"49","author":"Kirkwood","year":"1983","journal-title":"Thromb Haemost"},{"key":"key20261002090717_r8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1515\/cclm-2022-1122","article-title":"Standardization and harmonization in laboratory medicine: not only for clinical chemistry measurands.","volume":"61","author":"Plebani","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"key20261002090717_r9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/MBC.0b013e3283070872","article-title":"Comparison of optical and mechanical clot detection for routine coagulation testing in a large volume clinical laboratory.","volume":"19","author":"Bai","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"key20261002090717_r10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jcla.21497","article-title":"Optical and mechanical clot detection methodologies: a comparison study for routine coagulation testing.","volume":"26","author":"Tekkesin","year":"2012","journal-title":"J Clin Lab Anal"},{"key":"key20261002090717_r11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/ijlh.12295","article-title":"Validation of the Sysmex CS5100 coagulation analyzer and comparison to the Stago STA-R analyzer for routine coagulation parameters.","volume":"37","author":"Geens","year":"2015","journal-title":"Int J Lab Hematol"},{"key":"key20261002090717_r12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5937\/jomb0-56100","article-title":"A comparison of the optical method with the mechanical method in routine coagulation tests.","volume":"44","author":"\u00dclfer","year":"2025","journal-title":"J Med Biochem"},{"key":"key20261002090717_r13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/ijlh.12498","article-title":"Effects of haemolysis, icterus and lipaemia on coagulation tests as performed on Stago STA-Compact-Max analyser.","volume":"38","author":"Woolley","year":"2016","journal-title":"Int J Lab Hematol"},{"key":"key20261002090717_r14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/jth.13912","article-title":"Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians.","volume":"16","author":"Douxfils","year":"2018","journal-title":"J Thromb Haemost"},{"key":"key20261002090717_r15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1055\/s-0038-1627480","article-title":"International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants.","volume":"118","author":"Gosselin","year":"2018","journal-title":"Thromb Haemost"},{"key":"key20261002090717_r16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.chest.2016.08.1462","article-title":"Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants: A Systematic Review.","volume":"151","author":"Samuelson","year":"2017","journal-title":"Chest"},{"key":"key20261002090717_r17","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1478-3231.2008.01783.x","article-title":"Interlaboratory variability in assessment of the model of end-stage liver disease score.","volume":"28","author":"Lisman","year":"2008","journal-title":"Liver Int"},{"key":"key20261002090717_r18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/labmed\/lmx050","article-title":"Coagulation Testing in the Core Laboratory.","volume":"48","author":"Winter","year":"2017","journal-title":"Lab Med"},{"key":"key20261002090717_r19","first-page":"30","article-title":"Pre-analytical Factors Influencing Blood Sample Rejection Rate in the Hematology Laboratory of the Philippine General Hospital from 2018 to 2022: A Cross-sectional Study.","volume":"59","author":"Aquino","year":"2025","journal-title":"Acta Med Philipp"},{"key":"key20261002090717_r20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1515\/CCLM.2010.006","article-title":"Evaluation of errors in a clinical laboratory: A one-year experience.","volume":"48","author":"Goswami","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"key20261002090717_r21","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/jth.15239","article-title":"The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease.","volume":"19","author":"Lisman","year":"2021","journal-title":"J Thromb Haemost"},{"key":"key20261002090717_r22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40560-020-00517-5","article-title":"The effect of vitamin K on prothrombin time in critically ill patients: an observational registry study.","volume":"9","author":"Dahlberg","year":"2021","journal-title":"J Intensive Care"},{"key":"key20261002090717_r23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1055\/s-0039-1694995","article-title":"Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation.","volume":"46","author":"Iba","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"key20261002090717_r24","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1172\/JCI116814","article-title":"Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.","volume":"92","author":"Zivelin","year":"1993","journal-title":"J Clin Invest"},{"key":"key20261002090717_r25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1538-7933.2008.02827.x","article-title":"The international normalized ratio to prioritize patients for liver transplantation: problems and possible solutions.","volume":"6","author":"Tripodi","year":"2008","journal-title":"J Thromb Haemost"},{"key":"key20261002090717_r26","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/jth.15246","article-title":"Consumptive coagulopathy is associated with a disturbed host response in patients with sepsis.","volume":"19","author":"van Vught","year":"2021","journal-title":"J Thromb Haemost"},{"key":"key20261002090717_r27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13054-024-05001-2","article-title":"Vitamin K: a potential missing link in critical illness-a scoping review.","volume":"28","author":"Paulus","year":"2024","journal-title":"Crit Care"},{"key":"key20261002090717_r28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/ijlh.13584","article-title":"International Council for Standardisation in Haematology (ICSH) recommendations for collection of blood samples for coagulation testing.","volume":"43","author":"Kitchen","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"key20261002090717_r29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4103\/IJPM.IJPM_191_19","article-title":"Finish before the start: Analyzing preanalytical sample errors in a tertiary care hematology laboratory.","volume":"63","author":"Gaur","year":"2020","journal-title":"Indian J Pathol Microbiol"},{"key":"key20261002090717_r30","article-title":"Preanalytical Errors in a Hematology Laboratory: An Experience from a Tertiary Care Center.","volume":"13","author":"Iqbal","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"key20261002090717_r31"},{"key":"key20261002090717_r32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-0039-1692700","article-title":"Preanalytical Variables in Coagulation Testing: Setting the Stage for Accurate Results.","volume":"45","author":"Gosselin","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"key20261002090717_r33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.14345\/ceth.21002","article-title":"Validation of pre-analytical stability of specimens requested for various routine coagulation tests.","volume":"7","author":"Kim","year":"2021","journal-title":"Clin Exp Thromb Hemost."},{"key":"key20261002090717_r34","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0032-1319768","article-title":"Quality standards for sample processing, transportation, and storage in hemostasis testing.","volume":"38","author":"Adcock Funk","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"key20261002090717_r35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/bjh.16776","article-title":"Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis.","volume":"191","author":"Baker","year":"2020","journal-title":"Br J Haematol"},{"key":"key20261002090717_r36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cca.2013.07.033","article-title":"Quality indicators to detect pre-analytical errors in laboratory testing.","volume":"432","author":"Plebani","year":"2014","journal-title":"Clin Chim Acta"},{"key":"key20261002090717_r37","article-title":"Effect of anticoagulant adjustment on prothrombin time test using two different PT reagents in patients with elevated hematocrit.","volume":"22","author":"Silva","year":"2020","journal-title":"Pract Lab Med"},{"key":"key20261002090717_r38","doi-asserted-by":"crossref","first-page":"10797","DOI":"10.1038\/s41598-025-95389-w","article-title":"Effects of storage time and temperature on coagulation factor and natural anticoagulant activities in healthy individuals.","volume":"15","author":"Nakanishi","year":"2025","journal-title":"Sci Rep"},{"key":"key20261002090717_r39","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/bjh.19729","article-title":"Measurement of heparin, direct oral anti-coagulants and other non-coumarin anti-coagulants and their effects on haemostasis assays: A British Society for Haematology Guideline.","volume":"205","author":"Baker","year":"2024","journal-title":"Br J Haematol"},{"key":"key20261002090717_r40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-1-0716-3175-1_4","article-title":"Ultracentrifugation for Coagulation Testing.","volume":"2663","author":"Gosselin","year":"2023","journal-title":"Methods Mol Biol"},{"key":"key20261002090717_r41","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1055\/s-0028-1104538","article-title":"Standardization of the INR: how good is your laboratory\u2019s INR and can it be improved?","volume":"34","author":"Favaloro","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"key20261002090717_r42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12185-015-1820-2","article-title":"Clinical usefulness of international normalized ratio calibration of prothrombin time in patients with chronic liver disease.","volume":"102","author":"Lee","year":"2015","journal-title":"Int J Hematol"},{"key":"key20261002090717_r43"},{"key":"key20261002090717_r44","first-page":"271","article-title":"Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy with vitamin K antagonists.","volume":"979","author":"World Health Organization Expert Committee on Biological Standardization","year":"2013","journal-title":"WHO Technical Report Series."},{"key":"key20261002090717_r45","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/hep.21732","article-title":"The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation.","volume":"46","author":"Tripodi","year":"2007","journal-title":"Hepatology"},{"key":"key20261002090717_r46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1478-3231.2010.02358.x","article-title":"Low-molecular-weight heparin in patients with advanced cirrhosis.","volume":"31","author":"Bechmann","year":"2011","journal-title":"Liver Int"},{"key":"key20261002090717_r47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","article-title":"Calibrated automated thrombin generation measurement in clotting plasma.","volume":"33","author":"Hemker","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"key20261002090717_r48","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests.","volume":"41","author":"Tripodi","year":"2005","journal-title":"Hepatology"},{"key":"key20261002090717_r49","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"key":"key20261002090717_r50","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ajcp\/102.6.806","article-title":"The influence of the reference mean prothrombin time on the international normalized ratio.","volume":"102","author":"Critchfield","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"key20261002090717_r51"},{"key":"key20261002090717_r52","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.3390\/diagnostics14222521","article-title":"Innovative Diagnostic Solutions in Hemostasis.","volume":"14","author":"Favaloro","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"key20261002090717_r53","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/hematology.2024000666","article-title":"DOACs: role of anti-Xa and drug level monitoring.","volume":"2024","author":"Mithoowani","year":"2024","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"key20261002090717_r54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/ijlh.14020","article-title":"DOAC-stop can remove direct oral anticoagulants and allow analysis by global coagulation assays.","volume":"45","author":"Wang","year":"2023","journal-title":"Int J Lab Hematol"},{"key":"key20261002090717_r55","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.3390\/diagnostics12102520","article-title":"Novel Ex Vivo DOAC Removal Methods Reduce Interference in Lupus Anticoagulant Testing.","volume":"12","author":"Savola","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"key20261002090717_r56","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1055\/a-1450-8178","article-title":"2021 update of the International Council for Standardization in Haematology recommendations for laboratory measurement of direct oral anticoagulants.","volume":"121","author":"Douxfils","year":"2021","journal-title":"Thromb Haemost"},{"key":"key20261002090717_r57","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation.","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"key20261002090717_r58","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.3390\/diagnostics14161808","article-title":"Machine Learning for Patient-Based Real-Time Quality Control (PBRTQC), Analytical and Preanalytical Error Detection in Clinical Laboratory.","volume":"14","author":"Lorde","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"key20261002090717_r59","article-title":"Patient-based pre-classified real-time quality control with neural network (PCRTQC-NN).","volume":"47","author":"Zhou","year":"2025","journal-title":"Pract Lab Med"},{"key":"key20261002090717_r60","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1515\/cclm-2025-1322","article-title":"Implementation of AI systems in the clinical laboratory: insights from an expert survey and recommendations for best practice.","volume":"64","author":"Yang","year":"2026","journal-title":"Clin Chem Lab Med"},{"key":"key20261002090717_r61","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1055\/a-2778-9810","article-title":"Decoding Clot Waveform Analysis: Toward Better Understanding and Harmonization.","volume":"52","author":"Tan","year":"2026","journal-title":"Semin Thromb Hemost"},{"key":"key20261002090717_r62","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1515\/cclm-2025-0482","article-title":"Regulating the future of laboratory medicine: European regulatory landscape of AI-driven medical device software in laboratory medicine.","volume":"63","author":"\u00c7ubuk\u00e7u","year":"2025","journal-title":"Clin Chem Lab Med"},{"key":"key20261002090717_r63","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1093\/jalm\/jfaf106","article-title":"Regulatory Approved Point-of-Care Diagnostics (FDA & Health Canada): A Comprehensive Framework for Analytical Validity, Clinical Validity, and Clinical Utility in Medical Devices.","volume":"10","author":"Kardjadj","year":"2025","journal-title":"J Appl Lab Med"},{"key":"key20261002090717_r64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ajcp\/aqy087","article-title":"Benefits and Pitfalls of Point-of-Care Coagulation Testing for Anticoagulation Management: An ACLPS Critical Review.","volume":"151","author":"Wool","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"key20261002090717_r65"},{"key":"key20261002090717_r66","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/ijlh.14051","article-title":"ICSH guidance for INR and D-dimer testing using point of care testing in primary care.","volume":"45","author":"Fitzmaurice","year":"2023","journal-title":"Int J Lab Hematol"},{"key":"key20261002090717_r67","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.3390\/diagnostics14232683","article-title":"A Comprehensive Clinical Assessment of the LumiraDx International Normalized Ratio (INR) Assay for Point-of-Care Monitoring in Anticoagulation Therapy.","volume":"14","author":"Munir","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"key20261002090717_r68"},{"key":"key20261002090717_r69","doi-asserted-by":"crossref","first-page":"98","DOI":"10.36401\/JQSH-19-36","article-title":"Efficacy of Point-of-Care for INR Testing Compared to Standard Laboratory Methods at a Tertiary Care Hospital in Saudi Arabia.","volume":"3","author":"Bhat","year":"2020","journal-title":"Glob J Qual Saf Healthc"},{"key":"key20261002090717_r70","unstructured":"U.S. Food and Drug Administration. Class 1 Device Recall: INRatio\/INRatio2 PT\/INR Test Strips. Silver Spring, MD: U.S. Food and Drug Administration; 2014. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfRES\/res.cfm?id=126845. Accessed July 3, 2026."},{"key":"key20261002090717_r71","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/00365513.2018.1474492","article-title":"Warfarin monitoring with viscoelastic haemostatic assays, thrombin generation, coagulation factors and correlations to Owren and Quick prothrombin time.","volume":"78","author":"Nilsson","year":"2018","journal-title":"Scand J Clin Lab Invest"},{"key":"key20261002090717_r72","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jth.13549","article-title":"During warfarin induction, the Fiix-prothrombin time reflects the anticoagulation level better than the standard prothrombin time.","volume":"15","author":"Jonsson","year":"2017","journal-title":"J Thromb Haemost"},{"key":"key20261002090717_r73","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12959-021-00327-1","article-title":"Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article.","volume":"19","author":"Onundarson","year":"2021","journal-title":"Thromb J"},{"key":"key20261002090717_r74","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood.2020008698","article-title":"Ignoring instead of chasing after coagulation factor VII during warfarin management: an interrupted time series study.","volume":"137","author":"Oskarsdottir","year":"2021","journal-title":"Blood"},{"key":"key20261002090717_r75","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12959-025-00808-7","article-title":"Coagulation parameters reference interval for adult population of Debre Berhan town, Northeast Ethiopia.","volume":"23","author":"Kelem","year":"2025","journal-title":"Thromb J"},{"key":"key20261002090717_r76","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1538-7836.2007.02452.x","article-title":"Comparison of local International Sensitivity Index calibration and \u2018Direct INR\u2019 methods in correction of locally reported International Normalized Ratios: an international study.","volume":"5","author":"Poller","year":"2007","journal-title":"J Thromb Haemost"},{"key":"key20261002090717_r77","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ajcp\/aqv022","article-title":"Harmonizing the International Normalized Ratio (INR): standardization of methods and use of novel strategies to reduce interlaboratory variation and bias.","volume":"145","author":"Favaloro","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"key20261002090717_r78","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1373\/clinchem.2009.141937","article-title":"Simplified method for international normalized ratio (INR) derivation based on the prothrombin time\/INR line: an international study.","volume":"56","author":"Poller","year":"2010","journal-title":"Clin Chem"},{"key":"key20261002090717_r79","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2021.08.050","article-title":"MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.","volume":"161","author":"Kim","year":"2021","journal-title":"Gastroenterology"},{"key":"key20261002090717_r80","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1515\/cclm-2024-1292","article-title":"Behind the scenes of EQA\u2013characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part IV \u2013 Benefits for participant laboratories.","volume":"63","author":"Buchta","year":"2025","journal-title":"Clin Chem Lab Med"}],"container-title":["Biochemia medica"],"original-title":[],"link":[{"URL":"https:\/\/www.biochemia-medica.com\/en\/journal\/36\/3\/10.11613\/BM.2026.030504\/fullArticle","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:51:53Z","timestamp":1791283913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biochemia-medica.com\/en\/journal\/36\/3\/10.11613\/BM.2026.030504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":80,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,10,5]]},"published-print":{"date-parts":[[2026,10,15]]}},"URL":"https:\/\/doi.org\/10.11613\/bm.2026.030504","relation":{},"ISSN":["1846-7482","1330-0962"],"issn-type":[{"value":"1846-7482","type":"electronic"},{"value":"1330-0962","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,15]]}}}